相关实验视频
Updated: Jul 25, 2025

07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
5.6K
晚期结直肠癌转移的一个表观遗传特征
Euan J Rodger1, Gregory Gimenez1, Priyadarshana Ajithkumar1
1Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
iScience
|June 28, 2023
概括
结肠直肠癌 (CRC) 转移与DNA甲基化变化有关. 识别这些表观遗传标记可以改善晚期CRC的早期检测和治疗策略.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 基因组学就是基因组学.
背景情况:
- 结肠直肠癌 (CRC) 是一个主要的全球健康问题,转移是死亡的主要原因.
- 表观遗传变化,特别是DNA甲基化,与CRC进展和患者生存率降低有关.
- 了解CRC转移的分子驱动因素对于改善患者治疗结果至关重要.
研究的目的:
- 为了识别晚期结直肠癌转移的分子特征.
- 研究表观基因组变化在CRC转移中的作用.
- 发现转移性CRC的潜在治疗点.
主要方法:
- 全基因组规模的DNA甲基化分析对结合的初级CRC和肝转移.
- 配对初级CRC和肝转移的全转录组分析.
- 在DNA甲基化和基因表达模式之间的相关性分析.
主要成果:
- 在初级CRC和转移性瘤之间观察到DNA甲基化模式的显著差异.
- 一个基因组位置的子集表现出协调的甲基化表达变化,表明转移基因的表观遗传调节.
- 鉴定潜在的表观遗传驱动因素,涉及到结直肠癌的转移级联.
结论:
- 表观基因分析可以揭示与结直肠癌转移相关的关键标志物.
- 这些发现可能会改善CRC患者的预测结果.
- 已识别的表观遗传标记代表了转移性CRC的潜在新型治疗点.
更多相关视频
10:33Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
11.1K
08:12Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
5.5K
相关概念视频
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K